The effect of donor against recipient one-way HLA mismatch on liver transplantation outcomes from a multicenter

Sunghae Park1, Young Rok Choi2, Dong Jin Joo3

  • 1Department of Surgery, Samsung Medical Center, Sungkyunkwan University, School of Medicine, 50 Irwon-Dong, Gangnam-gu, Seoul, 135-710, Korea.

Scientific Reports
|December 15, 2023
PubMed

Insights

Donor against recipient one-way Human Leukocyte Antigen (HLA) mismatch significantly increases graft-versus-host disease (GVHD) and mortality after liver transplantation (LT). This mismatch is a critical risk factor for patient death and impacts overall survival in LT recipients.

Area of Science:

  • Transplantation Immunology
  • Hepatology

Background:

  • Donor against recipient one-way Human Leukocyte Antigen (HLA) mismatch (D→R one-way HLA MM) is associated with graft-versus-host disease (GVHD).
  • The impact of D→R one-way HLA MM on liver transplantation (LT) outcomes requires further investigation.

Purpose of the Study:

  • To investigate the clinical relevance of D→R one-way HLA MM in liver transplantation (LT).
  • To evaluate the association between D→R one-way HLA MM and patient outcomes, including GVHD and mortality.

Main Methods:

  • Retrospective analysis of 2670 patients undergoing LT between April 2014 and December 2020 from the Korean Organ Transplantation Registry database.
  • Patients were categorized into groups based on the presence or absence of D→R one-way HLA MM.
  • Outcomes including GVHD incidence, mortality rates, overall survival, rejection-free survival, and death-censored graft survival were compared between groups.

Main Results:

  • Eighteen patients (0.67%) exhibited D→R one-way HLA MM.
  • The D→R one-way HLA MM group showed significantly higher incidence of GVHD (22.2% vs. 0.3%) and mortality (38.9% vs. 11.6%).
  • D→R one-way HLA MM at 3 loci was a strong risk factor for GVHD (OR 163.3) and patient death (HR 12.75), leading to significantly lower overall survival (p<0.001).

Conclusions:

  • D→R one-way HLA MM at 3 loci is a significant risk factor impacting overall survival and GVHD incidence in liver transplant recipients.
  • The presence of D→R one-way HLA MM negatively affects patient survival post-LT.
  • No significant differences were observed in rejection-free survival and death-censored graft survival between groups.